Endogen ApS

Private limited companyCVR 29813337Aarhus CActive

Endogen ApS is a private limited company, based in Aarhus C, active in research and experimental development on natural sciences and engineering, founded in 2008. Equity was negative at the end of 2025 (−DKK 82,428). The company made a loss in both 2024 and 2025, most recently DKK 79,499. 5 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 113k+837.6% vs. 2024
Net profit−DKK 79,499−246.6% vs. 2024
Equity−DKK 82,428−2,715.2% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 22,939 to DKK 79,499 (2024 → 2025).

Employees

  • 1 more employees than a year earlier: 2 (08/2026) against 1 (08/2025).

Management and owners, last 24 months

  • New owners registered: Camilla Gustafsen Consulting ApS (31/05/2026), Simon Glerup Consulting ApS (31/05/2026) and Kollision ApS (23/06/2026).
  • No longer registered as owner: Kollision ApS (22/06/2026), Camilla Gustafsen Consulting ApS (30/05/2026) and Simon Glerup Consulting ApS (30/05/2026) (+1).

Registrations, last 24 months

  • 23/06/2026: Share capital changed from 145,000 DKK to 153,560 DKK
  • 31/05/2026: Moved to Universitetsbyen 76, 8000 Aarhus C
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 100k−DKK 80,000−DKK 60,000−DKK 40,000−DKK 20,000DKK 0DKK 20,000DKK 40,000DKK 60,000DKK 80,000202020212022202320242025
EquityNet profit
Financial figures for Endogen ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−18−23−15−19−15113+837.6%
Operating profit (EBIT)––−15–−15−67−335.5%
Profit before tax−18−24−15−19−23−79−246.6%
Net profit−18−24−15−19−23−79−246.6%
Total assets918986125129145+12.8%
Equity79543920−3−82−2,715.2%
Liabilities133447105132228+72.9%
Cash and cash equivalents131112445259+13.4%
Average number of employees1111110%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 200kDKK 0DKK 200kDKK 400kDKK 600kDKK 800k202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Negative equity

    Equity was −DKK 82,428 at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Endogen ApS
Financial yearPeriodPublishedFigures forDocuments
202527/10/2024 – 26/10/202510/02/2026The companyPDF not statedXBRL
202427/10/2023 – 26/10/202411/04/2025The companyPDFXBRL
202327/10/2022 – 26/10/202302/03/2024The companyPDFXBRL
202227/10/2021 – 26/10/202209/01/2023The companyPDFXBRL
202127/10/2020 – 26/10/202117/01/2022The companyPDFXBRL
202027/10/2019 – 26/10/202026/03/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0112204/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 113kNo. 246 of 421
Better than 42% of the companies in the industry
Equity−DKK 82,428No. 314 of 431
Better than 27% of the companies in the industry
Number of employees2No. 351 of 431
Better than 19% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 60,858of 69,742
Better than 13%
No. 62,026of 69,964
Better than 11%
Same industry and fewer than 20 employees329 companies in the comparison
No. 171of 323
Better than 47%
No. 224of 329
Better than 32%
Companies that are between 15 and 29 years old24,906 companies in the comparison
No. 22,105of 24,787
Better than 11%
No. 23,458of 24,905
Better than 6%
All companies of type ApS66,508 companies in the comparison
No. 58,516of 66,379
Better than 12%
No. 58,369of 66,505
Better than 12%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Endogen ApSDKK 113k
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Endogen ApS−DKK 79,499
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Endogen ApS−DKK 82,428
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Endogen ApS2
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Camilla Gustafsen Consulting ApS33.33%
  • Simon Glerup Consulting ApS33.33%
  • Kollision ApS15%
Endogen ApS

Management

1 active registrations

Executive management

Executive management at Endogen ApS
NameRoleAppointed
Simon Glerup PedersenDirector10/01/2019
Founders
Ib Glerup Nielsen, Simon Glerup Pedersen
Former management (1)
Former management at Endogen ApS
NameRoleAppointedResigned
Simon Glerup PedersenCEO27/10/200823/11/2018

Signing rule:  Selskabet tegnes af direktøren

Address and production units

1 active production units

Universitetsbyen 76
8000 Aarhus C

Aarhus Municipality · Postcode 8000

Other companies at the address (5)

  • MultiBiopsy ApSManufacture of medical and dental instruments and supplies
  • Heart2Heart ApSIT infrastructure, data processing, hosting and related activities
  • Capnova A/SOther financial service activities n.e.c.
  • Wenemea ApSResearch and experimental development on natural sciences and engineering
  • EntoPrime ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
ENDOGEN ApSUniversitetsbyen 76, 8000 Aarhus C21014836922

Purpose

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

The purpose is quoted from the register in Danish.

Changes year by year

48 registered events
202610 changescapital 1 · ownership 7 · address 1 · accounts 1
  • Share capital changed from 145,000 DKK to 153,560 DKK
  • KOLLISION ApS registered as owner (15%)
  • KOLLISION ApS is no longer registered as owner
  • Moved to Universitetsbyen 76, 8000 Aarhus C
  • Camilla Gustafsen Consulting ApS registered as owner (33.33%)
  • Simon Glerup Consulting ApS registered as owner (33.33%)
  • IMAS Holding ApS is no longer registered as owner
  • Camilla Gustafsen Consulting ApS is no longer registered as owner
  • Simon Glerup Consulting ApS is no longer registered as owner
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20232 changesaddress 1 · accounts 1
  • Moved to Universitetsbyen 14, 8000 Aarhus C
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20212 changesaddress 1 · accounts 1
  • Moved to Lerbækvej 9, 8240 Risskov
  • Annual report for 2020 published
201919 changesstatus 1 · capital 1 · ownership 16 · management 1
  • Status changed to active
  • Share capital changed from 126,000 DKK to 145,000 DKK
  • Simon Mølgaard Jensen registered as owner (25%)
  • Simon Mølgaard Jensen is no longer registered as owner
  • Camilla Gustafsen registered as owner (25%)
  • Camilla Gustafsen is no longer registered as owner
  • Simon Glerup Pedersen registered as owner (25%)
  • Simon Glerup Pedersen is no longer registered as owner
  • KOLLISION ApS registered as owner (10%)
  • Camilla Gustafsen Consulting ApS registered as owner (25%)
  • Simon Glerup Consulting ApS registered as owner (25%)
  • IMAS Holding ApS registered as owner (25%)
  • Simon Glerup Consulting ApS is no longer registered as owner
  • IMAS Holding ApS is no longer registered as owner
  • Camilla Gustafsen Consulting ApS is no longer registered as owner
  • Simon Mølgaard Jensen is no longer registered as owner
  • Camilla Gustafsen is no longer registered as owner
  • Simon Glerup Pedersen is no longer registered as owner
  • Simon Glerup Pedersen appointed director
20185 changesownership 3 · status 1 · management 1
  • Simon Glerup Consulting ApS registered as owner (33.33%)
  • IMAS Holding ApS registered as owner (33.33%)
  • Camilla Gustafsen Consulting ApS registered as owner (33.33%)
  • Status changed to under compulsory dissolution
  • Simon Glerup Pedersen stepped down as ceo
20151 changeaddress 1
  • Moved to Solsikkevej 8, 8240 Risskov
20142 changesownership 2
  • Simon Mølgaard Jensen registered as owner (25%)
  • Camilla Gustafsen registered as owner (25%)
20083 changesfounded 1 · management 1 · ownership 1
  • Registered as ENDOGEN ApS
  • Simon Glerup Pedersen appointed ceo
  • Simon Glerup Pedersen registered as owner (25%)

Related companies

Same industry in Aarhus

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction